Pharmaceutical Companies

CLICKS GROUP LTD

Country: 🇿🇦South Africa

Ownership: -

Established: -

Employees: -

Market Cap: $4.8B

Website: -

CLICKS GROUP LTD

🇿🇦South Africa

Ownership: -

Established: -

Employees: -

Market Cap: $4.8B

Website: -

APELLIS PHARMACEUTICALS, INC

Country: 🇺🇸United States

Ownership: Public

Established: 2008-01-01

Employees: 706

Market Cap: $4.8B

Website: http://www.apellis.com

APELLIS PHARMACEUTICALS, INC

🇺🇸United States

Ownership: Public

Established: 2008-01-01

Employees: 706

Market Cap: $4.8B

Website: http://www.apellis.com

BridgeBio Pharma

Country: 🇺🇸United States

Ownership: Public

Established: 2015-01-01

Employees: 556

Market Cap: $4.6B

Website: http://www.bridgebio.com

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Frank McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.

BridgeBio Pharma

🇺🇸United States

Ownership: Public

Established: 2015-01-01

Employees: 556

Market Cap: $4.6B

Website: http://www.bridgebio.com

Immunovant

Country: 🇺🇸United States

Ownership: Public, Subsidiary

Established: 2018-01-01

Employees: 207

Market Cap: $4.6B

Website: http://www.immunovant.com

Immunovant, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases. It is developing a novel, fully human monoclonal antibody IMVT-1401 that selectively binds to and inhibits the neonatal fragment crystallizable receptor. The company was founded in 2018 and is headquartered in New York, NY.

Immunovant

🇺🇸United States

Ownership: Public, Subsidiary

Established: 2018-01-01

Employees: 207

Market Cap: $4.6B

Website: http://www.immunovant.com

TAPOURI MARIA ANATOLI TOU NIKOLAOU

Country: 🇬🇷Greece

Ownership: -

Established: -

Employees: -

Market Cap: $4.6B

Website: -

TAPOURI MARIA ANATOLI TOU NIKOLAOU

🇬🇷Greece

Ownership: -

Established: -

Employees: -

Market Cap: $4.6B

Website: -

SANTEN PHARMACEUTICAL CO., LTD.

Country: 🇯🇵Japan

Ownership: Public

Established: 1890-01-01

Employees: 3.7K

Market Cap: $4.5B

Website: http://www.santen.co.jp

SANTEN PHARMACEUTICAL CO., LTD.

🇯🇵Japan

Ownership: Public

Established: 1890-01-01

Employees: 3.7K

Market Cap: $4.5B

Website: http://www.santen.co.jp

Telix Pharmaceuticals

Country: 🇦🇺Australia

Ownership: -

Established: -

Employees: 234

Market Cap: $4.5B

Website: -

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy....